Dimensional Fund Advisors
SGNT

Dimensional Fund Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Dimensional Fund Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-745,240
Closed -$11.2M – 3319
2016
Q2 		$11.2M Buy
745,240
+32,852
+5% +$422K 0.01% 2187
2016
Q1 		$8.67M Buy
712,388
+16,719
+2% +$234K 0.01% 2273
2015
Q4 		$11.1M Buy
695,669
+9,453
+1% +$149K 0.01% 2172
2015
Q3 		$10.5M Buy
686,216
+66,400
+11% +$1.44M 0.01% 2180
2015
Q2 		$15.1M Buy
619,816
+14,470
+2% +$347K 0.01% 2051
2015
Q1 		$14.1M Buy
605,346
+173,418
+40% +$4.59M 0.01% 2059
2014
Q4 		$10.8M Buy
431,928
+82,173
+23% +$2.41M 0.01% 2201
2014
Q3 		$10.9M Buy
349,755
+68,900
+25% +$1.87M 0.01% 2145
2014
Q2 		$7.26M Buy
280,855
+133,997
+91% +$2.98M 0.01% 2405
2014
Q1 		$3.43M Buy
146,858
+34,676
+31% +$758K ﹤0.01% 2688
2013
Q4 		$2.85M Buy
112,182
+47,071
+72% +$1.06M ﹤0.01% 2759
2013
Q3 		$1.33M Buy
+65,111
New +$1.45M ﹤0.01% 2973

Dimensional Fund Advisors's SGNT Position: Q3 2016 in Review

Dimensional Fund Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 745,240 shares — an estimated $11.2M sold.

Dimensional Fund Advisors first reported a position in SGNT in Q3 2013 and held it in 12 quarters. The position peaked at $15.1M in Q2 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Dimensional Fund Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Dimensional Fund Advisors sold 745,240 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $11.2M.
  • Dimensional Fund Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 12 quarters.
  • Dimensional Fund Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $15.1M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Dimensional Fund Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.